110 related articles for article (PubMed ID: 31111176)
1. Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease.
Kawaji Y; Nagata H; Muramatsu A; Kuriyama K; Ohshiro M; Hirakawa Y; Iwai T; Kobayashi T; Uchiyama H; Urata Y; Kuroda J
Ann Hematol; 2019 Jul; 98(7):1785-1787. PubMed ID: 31111176
[No Abstract] [Full Text] [Related]
2. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
[TBL] [Abstract][Full Text] [Related]
3. Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Gorospe L; Gallego-Rivera JI; Rioja-Martín ME; Chinea-Rodríguez A
Ann Hematol; 2017 Jun; 96(6):1059-1060. PubMed ID: 28374164
[No Abstract] [Full Text] [Related]
4. t(14;19)(q32;q13) incidence and significance in B-cell lymphoproliferative disorders.
Kelly RJ; Wright D; Patil K; Chapple M; Jalihal SS; Barrans SL; O'Connor SJ; Turner K; Jack AS; Owen RG
Br J Haematol; 2008 May; 141(4):561-3. PubMed ID: 18373708
[No Abstract] [Full Text] [Related]
5. Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial.
Fayad L; Ansell SM; Advani R; Coiffier B; Stuart R; Bartlett NL; Forero-Torres A; Kuliczkowski K; Belada D; Ng E; Drachman JG
Leuk Lymphoma; 2015; 56(9):2569-78. PubMed ID: 25651427
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Yamaguchi K; Kubota Y; Kishimori C; Ohno H; Kidoguchi K; Kizuka-Sano H; Nishioka A; Katsuya H; Ando T; Kimura S
Ann Hematol; 2020 Feb; 99(2):389-390. PubMed ID: 31848683
[No Abstract] [Full Text] [Related]
7. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
[TBL] [Abstract][Full Text] [Related]
8. Intravascular large B-cell lymphoma associated with t(14;19)(q32;q13) translocation.
Kobayashi T; Ohno H
Intern Med; 2011; 50(18):2007-10. PubMed ID: 21921386
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Simpson L; Ansell SM; Colgan JP; Habermann TM; Inwards DJ; Ristow KM; Johnston PB; Markovic SN; Micallef IN; Porrata LF; Witzig TE
Leuk Lymphoma; 2007 Jul; 48(7):1332-7. PubMed ID: 17613762
[TBL] [Abstract][Full Text] [Related]
10. A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Izumi K; Akasaka T; Honjo G; Haga H
Leuk Lymphoma; 2019 Mar; 60(3):825-828. PubMed ID: 30187810
[No Abstract] [Full Text] [Related]
11. Diffuse large B-cell lymphoma carrying both t(3 ; 7)(q27 ; p12) and t(8 ; 14)(q24 ; q32).
Katsura Y; Ohta I; Yoshida C; Ohtani H; Komeno T
Intern Med; 2011; 50(8):905-8. PubMed ID: 21498940
[TBL] [Abstract][Full Text] [Related]
12. Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Hertzberg M; Gandhi MK; Trotman J; Butcher B; Taper J; Johnston A; Gill D; Ho SJ; Cull G; Fay K; Chong G; Grigg A; Lewis ID; Milliken S; Renwick W; Hahn U; Filshie R; Kannourakis G; Watson AM; Warburton P; Wirth A; Seymour JF; Hofman MS; Hicks RJ;
Haematologica; 2017 Feb; 102(2):356-363. PubMed ID: 28143954
[TBL] [Abstract][Full Text] [Related]
13. Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.
Sarid N; Joffe E; Gibstein L; Avivi I; Polliack A; Perry C; Herishanu Y
Leuk Lymphoma; 2016 Jul; 57(7):1633-9. PubMed ID: 26643787
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
Elstrom RL; Andemariam B; Martin P; Ruan J; Shore TB; Coleman M; Leonard JP; Furman RR
Leuk Lymphoma; 2012 Aug; 53(8):1469-73. PubMed ID: 22263572
[TBL] [Abstract][Full Text] [Related]
15. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Griffin TC; Weitzman S; Weinstein H; Chang M; Cairo M; Hutchison R; Shiramizu B; Wiley J; Woods D; Barnich M; Gross TG;
Pediatr Blood Cancer; 2009 Feb; 52(2):177-81. PubMed ID: 18816698
[TBL] [Abstract][Full Text] [Related]
16. [Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Sakai R; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1105-8. PubMed ID: 16440771
[TBL] [Abstract][Full Text] [Related]
17. The t(9;14)(p13;q32) is a recurrent but rare abnormality in splenic marginal zone lymphoma.
Kelly RJ; O'connor SJ; Barrans SL; Johnson RJ; Owen RG
Leuk Lymphoma; 2007 Aug; 48(8):1636-7. PubMed ID: 17701598
[No Abstract] [Full Text] [Related]
18. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
19. [Malignant lymphoma complicated with posterior reversible encephalopathy].
Thomsen RH; Zakarian K; Hansen PB
Ugeskr Laeger; 2015 Sep; 177(37):V03150236. PubMed ID: 26376238
[TBL] [Abstract][Full Text] [Related]
20. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
